← Open Payments lookup

MARC JOHNSON: Open Payments

NPI 1700620622 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,110 in 112 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $174 · 2025 $2,110

Food & beverage: $2,110
CompanyPaymentsAmount
ABBVIE INC.27$587
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$338
Axsome Therapeutics, Inc.7$241
Otsuka America Pharmaceutical, Inc.13$176
JAZZ PHARMACEUTICALS INC.9$153
Neurocrine BioSciences, Inc.12$149
HARMONY BIOSCIENCES LLC3$79
Janssen Pharmaceuticals, Inc4$76
E.R. Squibb & Sons, L.L.C.4$65
Teva Pharmaceuticals USA, Inc.3$62

Products named: VRAYLAR, CAPLYTA, Auvelity, XYWAV, INGREZZA, REXULTI, WAKIX, ABILIFY MAINTENA.

Industry payments across NE — which companies pay providers there.